These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7747876)

  • 21. Susceptibility of low- and high-density lipoproteins from diabetic subjects to in vitro oxidative modification.
    Julier K; Mackness MI; Dean JD; Durrington PN
    Diabet Med; 1999 May; 16(5):415-23. PubMed ID: 10342342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus.
    Ukkola O; Kervinen K; Salmela PI; von Dickhoff K; Laakso M; Kesäniemi YA
    Atherosclerosis; 1993 Jun; 101(1):9-15. PubMed ID: 8216506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein levels in non-insulin-dependent diabetes mellitus with clinical macroangiopathy.
    Ikeda T; Ohtani I; Fujiyama K; Hoshino T; Tanaka Y; Tekeuchi T; Mashiba H
    Diabete Metab; 1991; 17(3):373-8. PubMed ID: 1884882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Very low density lipoprotein subfractions in Type II diabetes mellitus: alterations in composition and susceptibility to oxidation.
    McEneny J; O'Kane MJ; Moles KW; McMaster C; McMaster D; Mercer C; Trimble ER; Young IS
    Diabetologia; 2000 Apr; 43(4):485-93. PubMed ID: 10819243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes.
    Tsuzura S; Ikeda Y; Suehiro T; Ota K; Osaki F; Arii K; Kumon Y; Hashimoto K
    Metabolism; 2004 Mar; 53(3):297-302. PubMed ID: 15015140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
    Haffner SM; Agil A; Mykkanen L; Stern MP; Jialal I
    Diabetes Care; 1995 May; 18(5):646-53. PubMed ID: 8586002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages.
    Rosenblat M; Hayek T; Aviram M
    Atherosclerosis; 2006 Aug; 187(2):363-71. PubMed ID: 16226266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoproteins A-I and B in non-insulin-dependent diabetes mellitus.
    Lee LS; Hwang JY; Chang JJ; Hsu CH; Liao ST; Lo IL
    Taiwan Yi Xue Hui Za Zhi; 1989; 88(11-12):1139-42. PubMed ID: 2517634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [HLD-cholesterol and LDL-cholesterol in the blood in type I and II diabetes mellitus and the relation to atherogenesis].
    Felt V
    Vnitr Lek; 1986 Nov; 32(11):1066-72. PubMed ID: 3798773
    [No Abstract]   [Full Text] [Related]  

  • 30. Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Multiclinical Study for Diabetic Macroangiopathy (MSDM).
    Ito H; Harano Y; Suzuki M; Hattori Y; Takeuchi M; Inada H; Inoue J; Kawamori R; Murase T; Ouchi Y; Umeda F; Nawata H; Orimo H
    Diabetes; 1996 Jul; 45 Suppl 3():S19-23. PubMed ID: 8674883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormalities of low density lipoproteins in normolipidemic type II diabetic and nondiabetic patients with coronary artery disease.
    Tilly-Kiesi M; Syvänne M; Kuusi T; Lahdenperä S; Taskinen MR
    J Lipid Res; 1992 Mar; 33(3):333-42. PubMed ID: 1569383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Various parameters of lipid metabolism after intra-arterial injections of ozone in patients with ischemia of the lower extremities and diabetes mellitus].
    Sroczyński J; Antoszewski Z; Rudzki H; Matyszczyk B; Kuźniewicz R
    Pol Tyg Lek; 1990 Nov 19-26; 45(47-48):953-5. PubMed ID: 2104439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electronegative low density lipoprotein subform (LDL-) is increased in type 2 (non-insulin-dependent) microalbuminuric diabetic patients and is closely associated with LDL susceptibility to oxidation.
    Moro E; Zambon C; Pianetti S; Cazzolato G; Pais M; Bittolo Bon G
    Acta Diabetol; 1998 Oct; 35(3):161-4. PubMed ID: 9840454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Serum lipids in diabetes mellitus. Relation to equilibration and microangiopathy].
    Beylot M; Garcia I; Temori SA; Orgiazzi J; Revol A; Noel G
    Diabete Metab; 1983 Sep; 9(3):199-203. PubMed ID: 6653858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is glycation of low density lipoproteins in patients with Type 2 diabetes mellitus a LDL pre-oxidative condition?
    Moro E; Alessandrini P; Zambon C; Pianetti S; Pais M; Cazzolato G; Bon GB
    Diabet Med; 1999 Aug; 16(8):663-9. PubMed ID: 10477211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lipids and diabetic macroangiopathy: role of HDL].
    Fuller JH; Salter A; Mattock MB
    Journ Annu Diabetol Hotel Dieu; 1982; ():203-10. PubMed ID: 7098248
    [No Abstract]   [Full Text] [Related]  

  • 37. Susceptibility of LDL to oxidation is not associated with the presence of coronary heart disease or renal dysfunction in NIDDM patients.
    Leinonen JS; Rantalaiho V; Solakivi T; Koivula T; Wirta O; Pasternack A; Alho H; Lehtimäki T
    Clin Chim Acta; 1998 Jul; 275(2):163-74. PubMed ID: 9721074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased susceptibility to lipid oxidation of low-density lipoproteins and erythrocyte membranes from diabetic patients.
    Rabini RA; Fumelli P; Galassi R; Dousset N; Taus M; Ferretti G; Mazzanti L; Curatola G; Solera ML; Valdiguié P
    Metabolism; 1994 Dec; 43(12):1470-4. PubMed ID: 7990698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated beta2-glycoprotein I-low-density lipoprotein levels are associated with the presence of diabetic microvascular complications.
    Yu R; Yuan Y; Niu D; Song J; Liu T; Wu J; Wang J
    J Diabetes Complications; 2015; 29(1):59-63. PubMed ID: 25449980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of the physicochemical properties of LDL in type 2 diabetes.
    Scheffer PG; Teerlink T; Heine RJ
    Diabetologia; 2005 May; 48(5):808-16. PubMed ID: 15830178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.